An autopsy case of diffuse panbronchiolitis associated with lung cancer.
The prognosis of diffuse panbronchiolitis (DPB) has been remarkably improved after the development of low-dose erythromycin therapy, possibly due to anti-inflammatory rather than anti-infective mechanisms. Interestingly, DPB associated with lung cancer is quite rare. Here, we report an autopsy case of DPB who developed lung cancer after a long successful therapy with low-dose erythromycin.
Ishioka
S
S
Second Department of Internal Medicine, School of Medicine, Hiroshima University.
Hiyama
K
K
Nishisaka
T
T
Yokozaki
M
M
Maeda
H
H
Maeda
A
A
Jougasaki
Y
Y
Yamakido
M
M
D000230:Adenocarcinoma / Q000150:complications / Q000175:diagnosis; D000368:Aged; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D001344:Autopsy; D001988:Bronchiolitis / Q000150:complications* / Q000175:diagnosis / Q000188:drug therapy; D004917:Erythromycin / Q000627:therapeutic use; D005260:Female; D006801:Humans; D008175:Lung Neoplasms / Q000150:complications* / Q000175:diagnosis; D011379:Prognosis
D000900:Anti-Bacterial Agents; D004917:Erythromycin